Clinical Trial Update: Sildenafil Citrate in Waldenstrom's Macroglobulinemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sildenafil citrate for Waldenström macroglobulinemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• Sildenafil citrate (Sildenafil citrate)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Waldenstrom's Macroglobulinemia | Phase 2 | Status: COMPLETED